These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8433532)

  • 1. [Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation].
    Aramoto H; Saito H; Shigematsu H; Muto T
    Nihon Rinsho; 1993 Jan; 51(1):93-8. PubMed ID: 8433532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
    Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
    Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
    Taenaka N; Shimada Y; Hirata T; Nishijima MK; Takezawa J; Yoshiya I; Kambayashi J
    Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of disseminated intravascular coagulation with proteinase inhibitor].
    Okamoto K; Takeda S; Ohsato K
    Nihon Rinsho; 1991 Sep; 49(9):2130-5. PubMed ID: 1960878
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
    Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
    Isobe J
    Adv Exp Med Biol; 1979; 120B():385-94. PubMed ID: 229708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of disseminated intravascular coagulation with gabexate mesilate.
    Tamaki S; Wada H; Hiyoyama K; Shimura M; Minamikawa K; Wakita Y; Nakase T; Ohiwa M; Kaneko T; Iwasaki E
    Clin Ther; 1993; 15(6):1076-84. PubMed ID: 8111805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabexate as a therapy for disseminated intravascular coagulation.
    Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
    Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation.
    Kumon K; Tanaka K; Nakajima N; Naito Y; Fujita T
    Crit Care Med; 1984 Dec; 12(12):1039-43. PubMed ID: 6439471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
    Yoneda K; Amano I; Tanaka H; Yagi H; Tsukaguchi N; Morii T; Narita N
    Rinsho Ketsueki; 2001 Jan; 42(1):30-4. PubMed ID: 11235131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial.
    Maki M; Terao T; Ikenoue T; Takemura T; Sekiba K; Shirakawa K; Soma H
    Gynecol Obstet Invest; 1987; 23(4):230-40. PubMed ID: 3111953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of pre-disseminated intravascular coagulation state with gabexate mesilate (FOY)].
    Wada H; Suzuki H; Deguchi A; Mori Y; Okubo I; Tsuda M; Nagano T; Deguchi K; Shirakawa S
    Rinsho Ketsueki; 1986 Dec; 27(12):2243-8. PubMed ID: 3106677
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 2000 May; 27(5):767-74. PubMed ID: 10832450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthetic protease inhibitors for the treatment of DIC].
    Takahashi H
    Rinsho Byori; 2011 Feb; Suppl 147():152-8. PubMed ID: 21761764
    [No Abstract]   [Full Text] [Related]  

  • 16. [Disseminated intravascular coagulation (DIC) following open heart surgery and great vessel surgery. The result of early administration of gabexate mesilate (FOY)].
    Chihara K; Akiyama F; Shinozaki T; Shimamoto M; Takahashi K; Imura H; Yamazaki F; Kawarazaki S
    Kyobu Geka; 1984 Aug; 37(8):606-13. PubMed ID: 6438381
    [No Abstract]   [Full Text] [Related]  

  • 17. Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation?
    Nishiyama T; Matsukawa T; Hanaoka K
    Crit Care Med; 2000 May; 28(5):1419-22. PubMed ID: 10834689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of FUT-175 (nafamostat mesilate) on blood coagulation and experimental disseminated intravascular coagulation (DIC)].
    Koshiyama Y; Kobori A; Ogihara M; Yokomoto Y; Ohtani K; Shimamura K; Iwaki M
    Nihon Yakurigaku Zasshi; 1987 Dec; 90(6):313-20. PubMed ID: 3443413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti DIC therapy].
    Yahata M; Sakamoto Y
    Nihon Rinsho; 2016 Feb; 74(2):257-61. PubMed ID: 26915249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.